ABOUT
ClearPath Diagnostics
Headquarters
Syracuse, NY
Sector
Laboratory Services
With Shore Since
September 2011
INdependent Board Members
Robert DeCresce James Forrest Michael George Kevin Johnson
Exited
October 2016
Key Shore Contact
John Hennegan
In October 2016 Shore announced the sale of ClearPath Diagnostics (“ClearPath”), a leading provider of laboratory diagnostic services in the Northeastern United States, to Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH), the world’s leading healthcare diagnostics company. Together, Shore Capital and ClearPath executed a growth strategy that extended the company’s geographic reach to four states and expanded the service menu to include new cutting-edge tests. The growth was driven by organic initiatives as ClearPath expanded the sales force from one professional to a team of nine highly trained business development experts and implemented LEAN processes that ensured best-in-class turnaround times.
